T. Rowe Price Associates
NGVT icon

T. Rowe Price Associates’s Ingevity NGVT Stock Holding History

T. Rowe Price Associates’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.7M Buy
599,050
+557,209
+1,332% +$38.1M ﹤0.01% 823
2025
Q4 		$2.48M Buy
41,841
+1,467
+4% +$79.6K ﹤0.01% 1657
2025
Q3 		$2.23M Buy
40,374
+1,611
+4% +$83.8K ﹤0.01% 1686
2025
Q2 		$1.67M Buy
38,763
+912
+2% +$35.2K ﹤0.01% 1722
2025
Q1 		$1.5M Buy
37,851
+2,613
+7% +$116K ﹤0.01% 1749
2024
Q4 		$1.44M Buy
35,238
+2,541
+8% +$106K ﹤0.01% 1798
2024
Q3 		$1.28M Buy
32,697
+333
+1% +$13.3K ﹤0.01% 1864
2024
Q2 		$1.42M Buy
32,364
+1,146
+4% +$55.4K ﹤0.01% 1729
2024
Q1 		$1.49M Buy
31,218
+4,820
+18% +$217K ﹤0.01% 1711
2023
Q4 		$1.25M Buy
26,398
+1,572
+6% +$65.3K ﹤0.01% 1749
2023
Q3 		$1.18M Buy
24,826
+716
+3% +$39.1K ﹤0.01% 1719
2023
Q2 		$1.4M Sell
24,110
-278,069
-92% -$16.7M ﹤0.01% 1625
2023
Q1 		$21.6M Sell
302,179
-93,712
-24% -$7.44M ﹤0.01% 902
2022
Q4 		$27.9M Sell
395,891
-182
-0% -$12.8K ﹤0.01% 829
2022
Q3 		$24M Sell
396,073
-55,663
-12% -$3.73M ﹤0.01% 854
2022
Q2 		$28.5M Buy
451,736
+824
+0.2% +$53.7K ﹤0.01% 1063
2022
Q1 		$28.9M Sell
450,912
-33,495
-7% -$2.24M ﹤0.01% 1134
2021
Q4 		$34.7M Sell
484,407
-16,109
-3% -$1.23M ﹤0.01% 1126
2021
Q3 		$35.7M Sell
500,516
-18,110
-3% -$1.43M ﹤0.01% 1128
2021
Q2 		$42.2M Sell
518,626
-40,065
-7% -$3.22M ﹤0.01% 1090
2021
Q1 		$42.2M Sell
558,691
-60,707
-10% -$4.42M ﹤0.01% 1059
2020
Q4 		$46.9M Sell
619,398
-29,773
-5% -$1.94M ﹤0.01% 982
2020
Q3 		$32.1M Sell
649,171
-64,848
-9% -$3.66M ﹤0.01% 1012
2020
Q2 		$37.5M Sell
714,019
-44,573
-6% -$2.12M ﹤0.01% 940
2020
Q1 		$26.7M Sell
758,592
-4,866
-0.6% -$284K ﹤0.01% 978
2019
Q4 		$66.7M Sell
763,458
-1,812
-0.2% -$158K 0.01% 801
2019
Q3 		$64.9M Sell
765,270
-4,575
-0.6% -$408K 0.01% 772
2019
Q2 		$81M Sell
769,845
-3,382
-0.4% -$340K 0.01% 710
2019
Q1 		$81.7M Buy
773,227
+16,431
+2% +$1.65M 0.01% 696
2018
Q4 		$63.3M Buy
756,796
+11,492
+2% +$1.04M 0.01% 734
2018
Q3 		$75.9M Buy
745,304
+48,668
+7% +$4.7M 0.01% 763
2018
Q2 		$56.3M Buy
696,636
+74,833
+12% +$5.95M 0.01% 846
2018
Q1 		$45.8M Buy
621,803
+70,727
+13% +$5.29M 0.01% 908
2017
Q4 		$38.8M Buy
551,076
+93,304
+20% +$6.73M 0.01% 964
2017
Q3 		$28.6M Buy
457,772
+131,213
+40% +$7.77M ﹤0.01% 1061
2017
Q2 		$18.7M Buy
326,559
+37,186
+13% +$2.19M ﹤0.01% 1188
2017
Q1 		$17.6M Buy
289,373
+278,130
+2,474% +$15.7M ﹤0.01% 1205
2016
Q4 		$617K Sell
11,243
-204,117
-95% -$9.79M ﹤0.01% 1967
2016
Q3 		$9.93M Sell
215,360
-183,316
-46% -$7.74M ﹤0.01% 1321
2016
Q2 		$13.6M Buy
+398,676
New +$12.4M ﹤0.01% 1223

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

T. Rowe Price Associates's NGVT Position: Q1 2026 in Review

T. Rowe Price Associates increased its Ingevity (NGVT) stake by 1,332% in Q1 2026, buying an estimated $38.1M and bringing the position to 599,050 shares worth $42.7M. The position accounts for ﹤0.01% of the portfolio, ranked #823.

T. Rowe Price Associates first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $81.7M in Q1 2019. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • T. Rowe Price Associates held 599,050 shares of Ingevity worth $42.7M as of Q1 2026.
  • T. Rowe Price Associates bought 557,209 Ingevity shares in Q1 2026, an estimated $38.1M.
  • Ingevity made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #823 holding.
  • T. Rowe Price Associates first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
  • T. Rowe Price Associates's Ingevity position peaked at $81.7M in Q1 2019.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.